Clinical Trial of the Dual Vector Base Editor for the Treatment of the CHD3-R1025W Mutation
NCT06860672
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Developmental Delay Disorder
Intellectual Disability
Rare Diseases
Interventions
GENETIC:
Dual vector DNA base editor
Sponsor
Yongguo Yu